Oak Hill Bio and Chiesi have enrolled the first European patient in a Phase IIb study for OHB-607, to prevent BPD in infants.

New study reveals massive untapped potential in bio-waste capture with only 26 per cent of food waste currently collected ...

Credit: Puma Puma joined a two-year deal to accelerate the introduction of Carbios’ bio-recycling technology in 2022. The ...

Endevica Bio has launched a new spin-off company, Abisati, to accelerate its obesity candidate into clinical trials.

The company has made it easier to test for different protein modifications which are critical to the treatment of autoimmune ...

Bio-based thermoplastics are produced from renewable organic materials and can be recycled after use. Their resilience can be ...

J INTS BIO will oversee the entire project, managing clinical trials to validate AI-based predictions and develop clinically ...

Bio-based thermoplastics are produced from renewable organic materials and can be recycled after use. Their resilience can be improved by blending bio-based thermoplastics with other thermoplastics.

Unaudited quarterly revenue increased 10% year-on-year and 20% quarter-on-quarterHigher-margin, recurring cartridge revenue expected to surpass ...

Ayana Bio, the plant cell technology company making sustainable bioactives for consumer products, will have a presence at ...

Be Biopharma has raised $82m in financing to advance a gene therapy targeting hemophilia B to a Phase I/II trial, whilst also ...

INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, ...